EXPERIMENTALLY-INDUCED IMMUNE ACTIVATION IN NATURAL HOSTS OF SIVS
SIVS 自然宿主的实验诱导免疫激活
基本信息
- 批准号:7716304
- 负责人:
- 金额:$ 6.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-21 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAnimalsCD4 Positive T LymphocytesCD8B1 geneCellsCercopithecus pygerythrusChronicComputer Retrieval of Information on Scientific Projects DatabaseDenileukin DiftitoxDisease ProgressionFlow CytometryFundingGrantHLA-DR AntigensImmuneInfectionInflammatoryInstitutionMeasuresMethodsNumbersPatientsPeripheralPlasmaPolymerase Chain ReactionPopulationReportingResearchResearch PersonnelResistanceResourcesSIVSourceT-Cell ProliferationT-LymphocyteTimeUnited States National Institutes of HealthViralWeekconceptcytokineresearch study
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Background. Immune activation levels were reported to be the best predictor of disease progression in HIV-infected patients. However, there is no direct proof that induction of immune activation during chronic HIV/SIV infection increases viral replication. We therefore experimentally induced immune activation in SIVagm-infected African green monkeys (AGMs) a species resistant to AIDS.
Methods. Four SIVagm-infected AGMs were treated with ONTAK (Denileukin Diftitox) during chronic infection to deplete CD4+CD25+ T regulatory cells (Tregs). The dynamics of VL were measured by real-time PCR. Major T-cell populations and subsets were measured by flow-cytometry and the dynamics of pro-inflammatory cytokines in plasma was quantified by Luminex.
Results. Ontak did not induce a reduction in the number or function of Tregs in chronically SIV-infected AGMs. However, ONTAK administration induced a significant increase in immune activation in all animals as illustrated by the increases in HLA-DR and CD69 expression on both CD4+ and CD8+ T-cells. Increased CD4+ T-cell proliferation (Ki-67) was also observed, resulting in significant increases in the pool of peripheral CD4+ T-cells. Furthermore, significant increases in the levels of proinflammatory cytokines were observed after ONTAK administration. These changes persisted for three weeks after the initiation of each treatment and resulted in significant increases (2-4 log) in VLs in all animals.
Conclusion. We report the first successful experiment aimed at inducing immune activation in a natural host of SIV. Also, our results provide for the first time compelling proof-of concept that induction of immune activation during chronic SIV infection results in significant increases in viral replication, thus supporting the concept that immune activation is a key factor in disease progression during HIV/SIV infection.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
背景。据报道,免疫激活水平是HIV感染患者疾病进展的最佳预测指标。但是,没有直接证据表明,慢性艾滋病毒/SIV感染期间免疫激活的诱导会增加病毒复制。因此,我们在Sivagm感染的非洲绿猴(AGMS)中通过实验引起的免疫激活是一种对艾滋病的抗性物种。
方法。在慢性感染期间,用ONTAK(Denileukin Diftitox)处理了四个Sivagm感染的AGM,以耗尽CD4+ CD25+ T调节细胞(Tregs)。通过实时PCR测量VL的动力学。通过流量仪测量了主要的T细胞种群和亚集,并通过Luminex对血浆中促炎性细胞因子的动力学进行测量。
结果。 Ontak并未引起长期感染SIV感染的AGM中Treg的数量或功能的减少。然而,ONTAK给药诱导了所有动物的免疫激活显着增加,如CD4+和CD8+ T细胞上HLA-DR和CD69表达的增加所示。还观察到CD4+ T细胞增殖的增加(KI-67),导致外围CD4+ T细胞库显着增加。此外,在安塔克施用后观察到促炎细胞因子的水平显着增加。每种治疗开始后,这些变化持续了三周,并在所有动物的VLS中导致显着增加(2-4 log)。
结论。我们报告了旨在在SIV天然宿主中诱导免疫激活的第一个成功实验。同样,我们的结果首次提供了令人信服的概念,即慢性SIV感染期间免疫激活的诱导会导致病毒复制的显着增加,从而支持这样的概念,即免疫激活是HIV/SIV感染期间疾病进展的关键因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ivona Vasile Pandrea其他文献
Ivona Vasile Pandrea的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ivona Vasile Pandrea', 18)}}的其他基金
Probing the role of adenosine pathway in SIV pathogenesis
探讨腺苷途径在 SIV 发病机制中的作用
- 批准号:
10760676 - 财政年份:2023
- 资助金额:
$ 6.46万 - 项目类别:
Mechanistic Studies of Gut Dysfunction Exacerbation due to SARS-CoV-2 in HIV/SIV infected Individuals
HIV/SIV 感染者中 SARS-CoV-2 导致肠道功能恶化的机制研究
- 批准号:
10452676 - 财政年份:2021
- 资助金额:
$ 6.46万 - 项目类别:
Mechanistic Studies of Gut Dysfunction Exacerbation due to SARS-CoV-2 in HIV/SIV infected Individuals
HIV/SIV 感染者中 SARS-CoV-2 导致肠道功能恶化的机制研究
- 批准号:
10319695 - 财政年份:2021
- 资助金额:
$ 6.46万 - 项目类别:
Mechanistic Studies of Gut Dysfunction Exacerbation due to SARS-CoV-2 in HIV/SIV infected Individuals
HIV/SIV 感染者中 SARS-CoV-2 导致肠道功能恶化的机制研究
- 批准号:
10622542 - 财政年份:2021
- 资助金额:
$ 6.46万 - 项目类别:
Interventions to Reduce Hypercoagulability in Old SIV-Infected NHPs
降低感染 SIV 的旧 NHP 的高凝状态的干预措施
- 批准号:
8983585 - 财政年份:2015
- 资助金额:
$ 6.46万 - 项目类别:
Impact of NETosis on SIV Pathogenesis and Response to Treatment
NETosis 对 SIV 发病机制和治疗反应的影响
- 批准号:
10666361 - 财政年份:2015
- 资助金额:
$ 6.46万 - 项目类别:
Interventions to Reduce Hypercoagulability in Old SIV-Infected NHPs
降低感染 SIV 的旧 NHP 的高凝状态的干预措施
- 批准号:
9108998 - 财政年份:2015
- 资助金额:
$ 6.46万 - 项目类别:
Impact of NETosis on SIV Pathogenesis and Response to Treatment
NETosis 对 SIV 发病机制和治疗反应的影响
- 批准号:
10402152 - 财政年份:2015
- 资助金额:
$ 6.46万 - 项目类别:
Interventions to Reduce Hypercoagulability in Old SIV-Infected NHPs
降低感染 SIV 的旧 NHP 的高凝状态的干预措施
- 批准号:
9307988 - 财政年份:2015
- 资助金额:
$ 6.46万 - 项目类别:
Interventions to Reduce Hypercoagulability in Old SIV-Infected NHPs
降低感染 SIV 的旧 NHP 的高凝状态的干预措施
- 批准号:
9555307 - 财政年份:2015
- 资助金额:
$ 6.46万 - 项目类别:
相似国自然基金
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于基因组数据自动化分析为后生动物类群大规模开发扩增子捕获探针的实现
- 批准号:32370477
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
大型野生动物对秦岭山地森林林下植物物种组成和多样性的影响及作用机制
- 批准号:32371605
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
闸坝建设对河口大型底栖动物功能与栖息地演变的影响-以粤西鉴江口为例
- 批准号:42306159
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence
在 ART 开始时进行早期抗增殖治疗干预,以限制 SIV 的长期持续存在
- 批准号:
10849960 - 财政年份:2023
- 资助金额:
$ 6.46万 - 项目类别:
MultiOMICS mechanistic identification of predictors of HIV DNA decay, restoration of immune homeostasis and HIV specific immunity in PWH with cancer receiving Immune check point therapy
接受免疫检查点治疗的癌症患者中 HIV DNA 衰变、免疫稳态恢复和 HIV 特异性免疫的预测因子的多组学机制鉴定
- 批准号:
10731665 - 财政年份:2023
- 资助金额:
$ 6.46万 - 项目类别:
Blocking granzyme-mediated immune suppression to enhance HIV vaccine efficacy
阻断颗粒酶介导的免疫抑制以增强艾滋病毒疫苗的功效
- 批准号:
10673227 - 财政年份:2023
- 资助金额:
$ 6.46万 - 项目类别:
Tracing spatial organization of germinal centers in rhesus macaques
追踪恒河猴生发中心的空间组织
- 批准号:
10762072 - 财政年份:2023
- 资助金额:
$ 6.46万 - 项目类别:
Determining the Functional Significance of Mutations Observed in Envelope Protein Following Serial In Vivo Passaging of Human-Simian Immunodeficiency Virus
确定人猿免疫缺陷病毒体内连续传代后包膜蛋白中观察到的突变的功能意义
- 批准号:
10700374 - 财政年份:2023
- 资助金额:
$ 6.46万 - 项目类别: